Diabetes Research and Clinical Practice
Volume 82 , Pages S118-S121 , 15 December 2008

Continuous glucose monitoring in type 2 diabetes

References 

  1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993;329:977–986
  2. Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ. 2008;336:1177–1180
  3. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335:132
  4. Weschen LMC, Bloemendal E, Nijpels G, Heine RJ, Stalman WAB, Bouter LM. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin, The Cochrane Database of Systematic Reviews 2;2005: Art. No.:CD005060.
  5. American Diabetes Association . Standards of medical care in diabetes. Diabetes Care. 2008;S17
  6. Jamali R, Bachrach-Lindstrom M, Mohseni S. Continuous glucose monitoring system signals the occurrence of marked postprandial hyperglycemia in the elderly. Diabetes Technol. Ther. 2005;7:509–515
  7. Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol. Ther. 2003;5:19–26
  8. Kerr D. Continuous blood glucose monitoring: detection and prevention of hypoglycaemia. Int. J. Clin. Pract. Suppl. 2001;123:43
  9. Gross TM, Mastrototaro JJ, Fredrickson LP. Detection of unseen hypoglycemia using continuous glucose monitoring. Diabetologia. 2000;43:A19
  10. Weber KK, Lohmann T, Busch K, Donati-Hirsch I, Riel R. High frequency of unrecognized hypoglycemias in patients with type 2 diabetes is discovered by continuous glucose monitoring. Exp. Clin. Endocrinol. Diabetes. 2007;115:491–494
  11. Gelber A, Liberty IF, Perry ZH, Botach E, Harman-Boehm I. The effect of preprandial vs. postprandial administration of rapid-acting insulin analog on continuous glucose monitoring in type 1 diabetic patients. Diabetologia. 2008;S436
  12. Klonoff DC. Continuous glucose monitoring. Roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28:1231–1239
  13. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, et al. Use of continuous glucose monitoring system to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin. Proc. 2004;79:1521–1526
  14. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res. Clin. Pract. 1999;46:183–190
  15. Praet SF, Manders RJ, Lieverse AG, Kuipers H, Stehouwer CD, Keizer HA, et al. Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes. Med. Sci. Sports Exerc. 2006;38:2037–2044
  16. Nansel TR, Gellar L, McGill A, Carmack C. Effect of varying glycemic index meals on blood sugar control assessed by continuous glucose monitoring. Diabetes. 2007;0295
  17. Garg S, Zisser H, Schwartz S, Baily T, Kaplan R, Ellis S. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor. Diabetes Care. 2006;29:44–50
  18. Baily TS, Zisser HC, Garg SK. Reduction in hemoglobin A1c with real-time continuous glucose-monitoring: results from 12-week observational study. Diabetes Technol. Ther. 2007;9:203–210
  19. Garg SK, Hoff HK, Chase HP. The role of continuous glucose sensors in diabetes care. Endocrinol. Metab. N. Am. 2004;33:163–173
  20. Bode B, Gross K, Rikalo N, Schwartz S, Wahl S, Page C, et al. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol. Ther. 2004;6:105–113
  21. Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol. Ther. 2008;10:232–244
  22. Monnier L, Colette C, Boniface H. Contribution of postprandial glucose to chronic hyperglycemia: from the “glucose triad” to the trilogy of “sevens”. Diabetes Metab. 2006;32:2512–2517
  23. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681–1687
  24. Monnier L, Colette C, Boegner C, pham TC, Lapinski H, Boniface H. Continuous glucose monitoring in patents with type 2 diabetes. Why? When? Whom?. Diabetes Metab. 2007;33:247–252
  25. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52:2795–2804
  26. Temelkova-Kurtschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 2000;23:1830–1834
  27. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for glycemic complications. JAMA. 2006;295:1707–1708
  28. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moscs A, Owens D. Postprandial glucose regulation and diabetic complications. Arch. Int. Med. 2004;164:2090–2095
  29. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude excursions, a measure of diabetic instability. Diabetes. 1970;19:644–655
  30. Donicova V, Pallayova M, Donic V. CGMS reveals critical point in glycemic excursions requiring therapeutic intervention in people with type 2 diabetes with near normoglycemia on long-acting sulfonylurea. EASD. 2006;
  31. Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care. 2007;30:263–269
  32. Kovatchev B, Clarke W. Continuous Glucose Monitoring (CGM) reduces risks for hypo- and hyperglycemia and glucose variability in diabetes. In: Proceedings of the ADA. 2007;0086-OR [Abstract]
  33. Augestein P, Vogt L, Kohnert KD, Freyse EJ, Heinke P, Salzsieder E. Outpatient assessment of Karlsburg diabetes management system-based decision support. Diabetes Care. 2007;30:1704–1708

PII: S0168-8227(08)00465-8

doi: 10.1016/j.diabres.2008.09.051

Diabetes Research and Clinical Practice
Volume 82 , Pages S118-S121 , 15 December 2008

Article Tools

* Image Usage & Resolution